Published in J Virol on January 16, 2013
Keeping it quiet: chromatin control of gammaherpesvirus latency. Nat Rev Microbiol (2013) 1.13
KSHV: pathways to tumorigenesis and persistent infection. Adv Virus Res (2014) 0.99
Productive replication of human papillomavirus 31 requires DNA repair factor Nbs1. J Virol (2014) 0.94
KSHV LANA--the master regulator of KSHV latency. Viruses (2014) 0.91
Epigenetic regulation of EBV and KSHV latency. Curr Opin Virol (2013) 0.90
Kaposi's sarcoma-associated herpesvirus LANA recruits the DNA polymerase clamp loader to mediate efficient replication and virus persistence. Proc Natl Acad Sci U S A (2014) 0.87
Homologous Recombination Repair Factors Rad51 and BRCA1 Are Necessary for Productive Replication of Human Papillomavirus 31. J Virol (2015) 0.82
Modulation of the DNA damage response during the life cycle of human papillomaviruses. Virus Res (2016) 0.81
KSHV Genome Replication and Maintenance. Front Microbiol (2016) 0.78
A Screen for Extracellular Signal-Regulated Kinase-Primed Glycogen Synthase Kinase 3 Substrates Identifies the p53 Inhibitor iASPP. J Virol (2015) 0.77
The Modulation of Apoptotic Pathways by Gammaherpesviruses. Front Microbiol (2016) 0.76
G-quadruplex-interacting compounds alter latent DNA replication and episomal persistence of KSHV. Nucleic Acids Res (2016) 0.75
Genome-wide analysis of G-quadruplexes in herpesvirus genomes. BMC Genomics (2016) 0.75
Kaposi's Sarcoma Herpesvirus Latency-Associated Nuclear Antigen (LANA): Replicating and Shielding Viral DNA during Viral Persistence. J Virol (2017) 0.75
Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science (1994) 39.60
The global health burden of infection-associated cancers in the year 2002. Int J Cancer (2006) 13.57
The localization of replication origins on ARS plasmids in S. cerevisiae. Cell (1987) 13.29
A DNA replication mechanism for generating nonrecurrent rearrangements associated with genomic disorders. Cell (2007) 9.81
Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science (1999) 5.55
The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication. Cell (1989) 4.16
Kaposi's sarcoma and its associated herpesvirus. Nat Rev Cancer (2010) 3.55
Replication fork stalling at natural impediments. Microbiol Mol Biol Rev (2007) 3.47
Molecular anatomy and regulation of a stable replisome at a paused eukaryotic DNA replication fork. Genes Dev (2005) 3.07
swi1 and swi3 perform imprinting, pausing, and termination of DNA replication in S. pombe. Cell (2000) 2.96
Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer (2010) 2.68
DNA replication-timing analysis of human chromosome 22 at high resolution and different developmental states. Proc Natl Acad Sci U S A (2004) 2.66
KSHV infection and the pathogenesis of Kaposi's sarcoma. Annu Rev Pathol (2006) 2.61
Swi1 and Swi3 are components of a replication fork protection complex in fission yeast. Mol Cell Biol (2004) 2.55
The human Tim/Tipin complex coordinates an Intra-S checkpoint response to UV that slows replication fork displacement. Mol Cell Biol (2007) 2.54
Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event. Mol Cell Biol (2001) 2.44
The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells. J Virol (2002) 2.32
Replication stalling at unstable inverted repeats: interplay between DNA hairpins and fork stabilizing proteins. Proc Natl Acad Sci U S A (2008) 2.23
Latency-associated nuclear antigen (LANA) cooperatively binds to two sites within the terminal repeat, and both sites contribute to the ability of LANA to suppress transcription and to facilitate DNA replication. J Biol Chem (2002) 2.21
Replication slippage involves DNA polymerase pausing and dissociation. EMBO J (2001) 2.10
ORC, MCM, and histone hyperacetylation at the Kaposi's sarcoma-associated herpesvirus latent replication origin. J Virol (2004) 1.97
Tipin and Timeless form a mutually protective complex required for genotoxic stress resistance and checkpoint function. Proc Natl Acad Sci U S A (2006) 1.81
Visualization of DNA replication on individual Epstein-Barr virus episomes. Science (2001) 1.68
Mammalian TIMELESS and Tipin are evolutionarily conserved replication fork-associated factors. J Mol Biol (2006) 1.66
RNase-sensitive DNA modification(s) initiates S. pombe mating-type switching. Genes Dev (2004) 1.64
Disruption of Kaposi's sarcoma-associated herpesvirus latent nuclear antigen leads to abortive episome persistence. J Virol (2004) 1.64
Complex protein-DNA dynamics at the latent origin of DNA replication of Epstein-Barr virus. J Cell Sci (2003) 1.62
Recombination proteins mediate meiotic spatial chromosome organization and pairing. Cell (2010) 1.60
Human Timeless and Tipin stabilize replication forks and facilitate sister-chromatid cohesion. J Cell Sci (2010) 1.47
Cell cycle regulation of chromatin at an origin of DNA replication. EMBO J (2005) 1.40
Structure and function of latency-associated nuclear antigen. Curr Top Microbiol Immunol (2007) 1.39
DNA repeat rearrangements mediated by DnaK-dependent replication fork repair. Mol Cell (2006) 1.38
Human tumor-associated viruses and new insights into the molecular mechanisms of cancer. Oncogene (2008) 1.38
Plasticity of DNA replication initiation in Epstein-Barr virus episomes. PLoS Biol (2004) 1.34
Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus. J Virol (2004) 1.33
A method for preparing genomic DNA that restrains branch migration of Holliday junctions. Nucleic Acids Res (2000) 1.30
Telomere repeat binding factors TRF1, TRF2, and hRAP1 modulate replication of Epstein-Barr virus OriP. J Virol (2003) 1.27
Mapping replication origins in yeast chromosomes. Bioessays (1991) 1.26
Tandem repeat recombination induced by replication fork defects in Escherichia coli requires a novel factor, RadC. Genetics (1999) 1.24
Initiation of DNA replication within oriP is dispensable for stable replication of the latent Epstein-Barr virus chromosome after infection of established cell lines. J Virol (2000) 1.17
Characterization of the minimal replicator of Kaposi's sarcoma-associated herpesvirus latent origin. J Virol (2005) 1.16
Local and global functions of Timeless and Tipin in replication fork protection. Cell Cycle (2012) 1.15
Coordination of DNA replication and recombination activities in the maintenance of genome stability. J Cell Biochem (2011) 1.15
The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency. Future Microbiol (2011) 1.13
The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases. Recent Results Cancer Res (2002) 1.13
Methods to study replication fork collapse in budding yeast. Methods Enzymol (2006) 1.10
Checkpoint responses to unusual structures formed by DNA repeats. Mol Carcinog (2009) 1.07
Epstein-Barr virus episome stability is coupled to a delay in replication timing. J Virol (2008) 1.02
Recombination at DNA replication fork barriers is not universal and is differentially regulated by Swi1. Proc Natl Acad Sci U S A (2009) 0.93
Single molecule analysis of replicated DNA reveals the usage of multiple KSHV genome regions for latent replication. PLoS Pathog (2011) 0.87
"Chromosome kissing" and modulation of replication termination. Bioarchitecture (2011) 0.85
The replisome pausing factor Timeless is required for episomal maintenance of latent Epstein-Barr virus. J Virol (2011) 0.84
Timeless links replication termination to mitotic kinase activation. PLoS One (2011) 0.84
Damage induced in episomal EBV DNA in Raji cells by antitumor drugs as measured by pulsed field gel electrophoresis. Anal Biochem (1994) 0.82
Mapping origins of DNA replication in eukaryotes. Methods Mol Biol (2005) 0.82
The dyad symmetry element of Epstein-Barr virus is a dominant but dispensable replication origin. PLoS One (2011) 0.81
The diversity of human cancer viruses. Curr Opin Virol (2012) 0.76
Cohesins localize with CTCF at the KSHV latency control region and at cellular c-myc and H19/Igf2 insulators. EMBO J (2008) 4.28
The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA. Science (2006) 3.46
TERRA RNA binding to TRF2 facilitates heterochromatin formation and ORC recruitment at telomeres. Mol Cell (2009) 2.60
The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60. Mol Cell Biol (2004) 2.13
Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes. J Virol (2006) 2.11
Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway. J Virol (2010) 1.98
ORC, MCM, and histone hyperacetylation at the Kaposi's sarcoma-associated herpesvirus latent replication origin. J Virol (2004) 1.97
A charged and contoured surface on the nucleosome regulates chromatin compaction. Nat Struct Mol Biol (2007) 1.95
Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence. J Virol (2008) 1.86
Telomeric proteins regulate episomal maintenance of Epstein-Barr virus origin of plasmid replication. Mol Cell (2002) 1.76
Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency. J Virol (2003) 1.70
Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcoma-associated herpesvirus lytic transcription. J Virol (2006) 1.57
The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 N terminus is essential for chromosome association, DNA replication, and episome persistence. J Virol (2004) 1.49
The Kaposi's sarcoma-associated herpesvirus K12 transcript from a primary effusion lymphoma contains complex repeat elements, is spliced, and initiates from a novel promoter. J Virol (2002) 1.41
Cell cycle regulation of chromatin at an origin of DNA replication. EMBO J (2005) 1.40
Snapshots: chromatin control of viral infection. Virology (2013) 1.39
An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions. Cell Host Microbe (2012) 1.38
ORC binding to TRF2 stimulates OriP replication. EMBO Rep (2006) 1.38
RNA-dependent recruitment of the origin recognition complex. EMBO J (2008) 1.37
The origin recognition complex localizes to telomere repeats and prevents telomere-circle formation. Curr Biol (2007) 1.36
Chromatin profiling of Epstein-Barr virus latency control region. J Virol (2007) 1.34
Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus. J Virol (2004) 1.33
Role for G-quadruplex RNA binding by Epstein-Barr virus nuclear antigen 1 in DNA replication and metaphase chromosome attachment. J Virol (2009) 1.29
CTCF prevents the epigenetic drift of EBV latency promoter Qp. PLoS Pathog (2010) 1.27
Telomere repeat binding factors TRF1, TRF2, and hRAP1 modulate replication of Epstein-Barr virus OriP. J Virol (2003) 1.27
KSHV LANA1 binds DNA as an oligomer and residues N-terminal to the oligomerization domain are essential for DNA binding, replication, and episome persistence. Virology (2004) 1.24
Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF. J Virol (2006) 1.24
The cigarette smoke carcinogen benzo[a]pyrene enhances human papillomavirus synthesis. J Virol (2007) 1.22
A role for CTCF and cohesin in subtelomere chromatin organization, TERRA transcription, and telomere end protection. EMBO J (2012) 1.21
Epigenetic control of replication origins. Cell Cycle (2005) 1.19
Coordination of KSHV latent and lytic gene control by CTCF-cohesin mediated chromosome conformation. PLoS Pathog (2011) 1.16
Timeless preserves telomere length by promoting efficient DNA replication through human telomeres. Cell Cycle (2012) 1.16
EBV latency types adopt alternative chromatin conformations. PLoS Pathog (2011) 1.15
EBV tegument protein BNRF1 disrupts DAXX-ATRX to activate viral early gene transcription. PLoS Pathog (2011) 1.14
The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency. Future Microbiol (2011) 1.13
Inherited mutations in the helicase RTEL1 cause telomere dysfunction and Hoyeraal-Hreidarsson syndrome. Proc Natl Acad Sci U S A (2013) 1.13
Chromatin organization of gammaherpesvirus latent genomes. Biochim Biophys Acta (2009) 1.12
Initiation of Epstein-Barr virus lytic replication requires transcription and the formation of a stable RNA-DNA hybrid molecule at OriLyt. J Virol (2010) 1.09
Determination of Kaposi's sarcoma-associated herpesvirus C-terminal latency-associated nuclear antigen residues mediating chromosome association and DNA binding. J Virol (2007) 1.09
Cohesins repress Kaposi's sarcoma-associated herpesvirus immediate early gene transcription during latency. J Virol (2012) 1.08
The KSHV latency-associated nuclear antigen: a multifunctional protein. Front Biosci (2002) 1.07
Neuroendocrine carcinoma of the uterine cervix: A clinicopathologic retrospective study of 31 cases with prognostic implications. J Chemother (2006) 1.06
Inhibition of Epstein-Barr virus OriP function by tankyrase, a telomere-associated poly-ADP ribose polymerase that binds and modifies EBNA1. J Virol (2005) 1.06
Identification of host-chromosome binding sites and candidate gene targets for Kaposi's sarcoma-associated herpesvirus LANA. J Virol (2012) 1.05
A redox-sensitive cysteine in Zta is required for Epstein-Barr virus lytic cycle DNA replication. J Virol (2005) 1.04
Cell cycle control of Kaposi's sarcoma-associated herpesvirus latency transcription by CTCF-cohesin interactions. J Virol (2009) 1.03
Epstein-Barr virus episome stability is coupled to a delay in replication timing. J Virol (2008) 1.02
Kaposi's sarcoma herpesvirus C-terminal LANA concentrates at pericentromeric and peri-telomeric regions of a subset of mitotic chromosomes. Virology (2006) 1.02
14-3-3 binding sites in the snail protein are essential for snail-mediated transcriptional repression and epithelial-mesenchymal differentiation. Cancer Res (2010) 1.01
Kaposi's sarcoma-associated herpesvirus LANA hitches a ride on the chromosome. Cell Cycle (2006) 1.01
TERRA, CpG methylation and telomere heterochromatin: lessons from ICF syndrome cells. Cell Cycle (2010) 1.01
Cleavage of TFIIA by Taspase1 activates TRF2-specified mammalian male germ cell programs. Dev Cell (2013) 1.01
Definition of sequence requirements for latency-associated nuclear antigen 1 binding to Kaposi's sarcoma-associated herpesvirus DNA. J Virol (2004) 1.01
Genome-wide analysis of host-chromosome binding sites for Epstein-Barr Virus Nuclear Antigen 1 (EBNA1). Virol J (2010) 1.00
Role of Kaposi's sarcoma-associated herpesvirus C-terminal LANA chromosome binding in episome persistence. J Virol (2009) 0.99
The CBP bromodomain and nucleosome targeting are required for Zta-directed nucleosome acetylation and transcription activation. Mol Cell Biol (2003) 0.96
Regulation of Epstein-Barr virus OriP replication by poly(ADP-ribose) polymerase 1. J Virol (2010) 0.96
Epstein-Barr virus immediate-early protein Zta co-opts mitochondrial single-stranded DNA binding protein to promote viral and inhibit mitochondrial DNA replication. J Virol (2008) 0.96
Molecular basis for oligomeric-DNA binding and episome maintenance by KSHV LANA. PLoS Pathog (2013) 0.95
DNA affinity purification of Epstein-Barr virus OriP-binding proteins. Methods Mol Biol (2005) 0.95
The internal Kaposi's sarcoma-associated herpesvirus LANA regions exert a critical role on episome persistence. J Virol (2011) 0.94
A role for MRE11, NBS1, and recombination junctions in replication and stable maintenance of EBV episomes. PLoS One (2007) 0.94
Discovery of selective inhibitors against EBNA1 via high throughput in silico virtual screening. PLoS One (2010) 0.94
Mechanism of glycyrrhizic acid inhibition of Kaposi's sarcoma-associated herpesvirus: disruption of CTCF-cohesin-mediated RNA polymerase II pausing and sister chromatid cohesion. J Virol (2011) 0.93
CTCF binding site sequence differences are associated with unique regulatory and functional trends during embryonic stem cell differentiation. Nucleic Acids Res (2013) 0.92
Development of a high-throughput screen for inhibitors of Epstein-Barr virus EBNA1. J Biomol Screen (2010) 0.91
CTCF regulates Kaposi's sarcoma-associated herpesvirus latency transcription by nucleosome displacement and RNA polymerase programming. J Virol (2012) 0.90
Epigenetic regulation of EBV and KSHV latency. Curr Opin Virol (2013) 0.90
Formation of telomeric repeat-containing RNA (TERRA) foci in highly proliferating mouse cerebellar neuronal progenitors and medulloblastoma. J Cell Sci (2012) 0.88
Cell cycle association of the retinoblastoma protein Rb and the histone demethylase LSD1 with the Epstein-Barr virus latency promoter Cp. J Virol (2008) 0.87
Murine gammaherpesvirus 68 LANA acts on terminal repeat DNA to mediate episome persistence. J Virol (2012) 0.87
Interpreting the Epstein-Barr Virus (EBV) epigenome using high-throughput data. Viruses (2013) 0.86
Newer beta-lactam antibiotics: doripenem, ceftobiprole, ceftaroline, and cefepime. Med Clin North Am (2011) 0.85
Epigenetic deregulation of the LMP1/LMP2 locus of Epstein-Barr virus by mutation of a single CTCF-cohesin binding site. J Virol (2013) 0.85
Timeless links replication termination to mitotic kinase activation. PLoS One (2011) 0.84
The replisome pausing factor Timeless is required for episomal maintenance of latent Epstein-Barr virus. J Virol (2011) 0.84
Therapeutic doses of hydroxyurea cause telomere dysfunction and reduce TRF2 binding to telomeres. Cancer Biol Ther (2009) 0.84
Rapid and quantitative assessment of KSHV LANA-mediated DNA replication. Arch Virol (2011) 0.83
Crystal structure of the gamma-2 herpesvirus LANA DNA binding domain identifies charged surface residues which impact viral latency. PLoS Pathog (2013) 0.83
Identification of Kaposi's sarcoma-associated herpesvirus LANA regions important for episome segregation, replication, and persistence. J Virol (2013) 0.83
Initiation of lytic DNA replication in Epstein-Barr virus: search for a common family mechanism. Future Virol (2010) 0.82
Evidence for DNA hairpin recognition by Zta at the Epstein-Barr virus origin of lytic replication. J Virol (2010) 0.81
Newer beta-lactam antibiotics: doripenem, ceftobiprole, ceftaroline, and cefepime. Infect Dis Clin North Am (2009) 0.81
Regulation of Epstein-Barr virus origin of plasmid replication (OriP) by the S-phase checkpoint kinase Chk2. J Virol (2010) 0.81
Bioactive activities of natural products against herpesvirus infection. J Microbiol (2013) 0.81
Beta-lactam antibiotics: newer formulations and newer agents. Infect Dis Clin North Am (2004) 0.80
Telomeres and viruses: common themes of genome maintenance. Front Oncol (2012) 0.80
Multivalent sequence recognition by Epstein-Barr virus Zta requires cysteine 171 and an extension of the canonical B-ZIP domain. J Virol (2006) 0.80
Stabilization of Myc through heterotypic poly-ubiquitination by mLANA is critical for γ-herpesvirus lymphoproliferation. PLoS Pathog (2013) 0.79
KSHV LANA's expanding bag of tricks. Blood (2008) 0.78
Kaposi's sarcoma-associated herpesvirus virion-induced transcription activation of the ORF50 immediate-early promoter. J Virol (2005) 0.78
Identification of protein tyrosine kinases required for B-cell- receptor-mediated activation of an Epstein-Barr Virus immediate-early gene promoter. J Virol (2004) 0.78
A short sequence immediately upstream of the internal repeat elements is critical for KSHV LANA mediated DNA replication and impacts episome persistence. Virology (2013) 0.78
Two major histocompatibility complex class I-restricted epitopes of the Borna disease virus p10 protein identified by cytotoxic T lymphocytes induced by DNA-based immunization. J Virol (2003) 0.77
Topoisomerase I and RecQL1 function in Epstein-Barr virus lytic reactivation. J Virol (2009) 0.77